PF-05221304
Kwaliteit
ISO Gecertificeerd
Levering
24-48 uur
Technische Specificaties
1370448-25-1
NSC 170984, R 6238, STAT5 Inhibitor III
C11655-5mg
Acetyl-CoA carboxylase
Metabolism
COC1=CC (=CC (=N1) C2=CC=C (C=C2) C (O) =O) C (=O) N3CCC4 (CC3) CC (=O) C5=C (C4) C=N[N]5C (C) C
C28H30N4O5
PF-05221304 is an orally bioavailable, liver-targeted inhibitor of acetyl-CoA carboxylase (ACC), an enzyme that catalyzes the first committed step in de novo lipogenesis (DNL) .
3 years -20°C powder
Beschrijving
PF-05221304 Beschikbaar in 5 mg. Bestel eenvoudig online met snelle levering.
Specificaties
Recent bekeken producten
Anti-TNF-α (Adalimumab), humanized Antibody
A1048-100
100 µg
PEPTIC DIGEST OF ANIMAL TISSUE (MEAT PEPTONE)
P16-102-01
500 g
GelRed® Agarose LE
#41029-5G
1x 5 g
HT115 (DE3) Super Competent Cells
D1045S
10x 100 μL
HT115
ACC-130
10 Tubes
Rat Reticulon-4 receptor, RTN4R ELISA Kit
MBS9325746-01
48 Well
Starfish Genomic DNA
GSF-390
0.025 mg
NPM2
570475-01
50 µg
Recent gezochte producten
Anti-EGFR Antibody (aa1048-1077) IHC-plus
MBS2400374-01
0.2 mL
BIBR-1048 10mg
A10139-10
10 mg
BIBR-1048 100mg
A10139-100
100 mg
BIBR-1048 10mM * 1mL in DMSO
A10139-10mM-D
10 mM x 1mL in DMSO
MK-2048 100mg
A11135-100
100 mg
Ro 61-8048 100mg
A12833-100
100 mg
MMV390048 100mg
A13566-100
100 mg
VCE-004.8 100mg
A18549-100
100 mg